Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results

Autor: Gener-Ricos, Georgina, Haddad, Fadi G., Sasaki, Koji, Issa, Ghayas C., Skinner, Jeffrey, Masarova, Lucia, Borthakur, Gautam, Alvarado, Yesid, Garcia-Manero, Guillermo, Jabbour, Elias, Kantarjian, Hagop
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia October 2023 23(10):742-748
Databáze: ScienceDirect
Externí odkaz: